ISRG Stock Recent News
ISRG LATEST HEADLINES
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q2 2025 Earnings Conference Call July 22, 2025 4:30 PM ET Company Participants David J. Rosa - CEO & Director Jamie E.
The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.78 per share a year ago.
Intuitive Surgical beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by growing demand for its surgical robots used in minimally invasive procedures.
Intuitive Surgical stock fell late Tuesday after the robotic surgery giant beat second-quarter forecasts and slightly raised its guidance.
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2025.
Intuitive Surgical's premium valuation is justified by consistent mid-teens growth, a dominant market position, and a resilient razor-and-blade business model. Recent innovations like telesurgery and regulatory approvals further expand the company's total addressable market and reinforce its competitive moat. Risks include potential tariff impacts and capital return missteps, but a strong balance sheet and recurring revenues mitigate these concerns.
As robotic-assisted surgery continues its rising adoption in modern medicine, two industry leaders — Intuitive Surgical ISRG and Stryker SYK — are shaping the future of robotic-assisted surgery. Intuitive, renowned for its da Vinci Surgical System, continues to dominate the soft tissue surgery space.
Intuitive Surgical's second-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.